White matter lesions and vascular cognitive impairment: Part 1: Typical and unusual causes

Clinical Neuroradiology

Volumn 22, Issue 3, 2012, Pages 193-210

  Nichtweiss M ^b   Weidauer, S ^a,c   Treusch, N ^d   Hattingen, E ^d  

^a Sankt Katharinen Krankenhaus GmbH   (Germany)

^b Teaching Hospital of the Goethe University ^*  (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Cognitive impairment; Differential diagnosis; Magnetic resonance imaging; Vascular disease; White matter changes

Indexed keywords

AGE DISTRIBUTION; ANTIPHOSPHOLIPID SYNDROME; BEHCET DISEASE; BRAIN ATROPHY; BRAIN EDEMA; BRAIN SIZE; BRAIN STEM; BRAIN VASCULITIS; CADASIL; CEREBELLUM; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; EXTERNAL CAPSULE; FABRY DISEASE; FAMILY HISTORY; FEVER; HEADACHE; HUMAN; LYMPHOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MELAS SYNDROME; MICROANGIOPATHY; MIGRAINE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; REVIEW; SARCOIDOSIS; SEIZURE; SICKLE CELL ANEMIA; SUSAC SYNDROME; VASCULAR AMYLOIDOSIS; VASCULAR COGNITIVE IMPAIRMENT; VISUAL DISORDER; WHITE MATTER LESION;

EID: 84866369049     PISSN: 18691439     EISSN: 18691447     Source Type: Journal    
DOI: 10.1007/s00062-012-0134-5     Document Type: Review

References (137)

1. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis. 2002;13(Suppl 2):7-10.
2. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987;44:21-3.
3. W ahlund LO, Agartz I, Almqvist O, Basun H, Forssell L, Sääf J, et al. The brain in healthy aged individuals: MR imaging. Radiology. 1990;174:675-9.
4. E nglund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain. 1988;111:1425-39.
5. Ferrer I, Bella R, Serrano MT, Martí E, Guionnet N. Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. J Neurol Sci. 1990;98:37-50.
6. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652-59.
7. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HD. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-36.
8. C hui H. Neuropathology lessons in vascular dementia. Alzheimer Dis Assoc Disord. 2005;19:45-52.
9. Jellinger KA. Understanding the pathology of vascular cognitive impairment. J Neurol Sci. 2005;229-230:57-63.
10. Barkhof F, Fox NC, Bastos-Leite AJ, Scheltens P. Neuroimaging in dementia. Berlin: Springer, 2011.
11. Selnes OA, Vinters HV. Vascular cognitive impairment. Nat Clin Pract Neurol. 2006;2:538-47.
12. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
13. C aplan LR, Gomes JA. Binswanger disease-an update. J Neurol Sci. 2010;299:9-10.
14. Geerlings MI, Appelman AP, Vincken KL, Mali WP, Van Der Graaf Y, et al. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study. Am J Epidemiol. 2009;170:1147-55.
15. Frisoni GB, Galluzzi S, Pantoni L, Filippi M. The effect of white matter lesions on cognition in the elderly-small but detectable. Nat Clin Pract Neurol. 2007;3:620-27.
16. Buning T, Kugel H, Knecht S. Excellent cognitive performance despite massive cerebral white matter changes. Neuroradiology. 2005;47:749-52.
17. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-60.
18. van Straaten EC, Fazekas F, Rostrup E, Scheltens P, Schmidt R, Pantoni L, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke. 2006;37:836-40.
19. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke. 2006;37:2220-41.
20. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008;7:246-55.
21. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9:793-806.
22. Dichgans M. CADASIL: a monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis. 2002;13(Suppl 2):37-41.
23. V itali P, Migliaccio R, Agosta F, Rosen HJ, Geschwind MD. Neuroimaging in dementia. Semin Neurol. 2008;28:467-83.
24. Guermazi A, Miaux Y, Rovira-Canellas A, Suhy J, Pauls J, Lopez R, et al: Neuroradiological findings in vascular dementia. Neuroradiology. 2007;49:1-22.
25. Josephs KA. Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64:4-14.
26. C haril A, Yousry TA , Rovaris M, Barkhof F, De Stefano N, Fazekas F, et al. MRI in the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol. 2006;5:841-52.
27. Küker W, Gaertner S, Nagele T, Dopfer C, Schoning M, Fiehler J, et al. Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis. Cerebrovasc Dis. 2008;26:23-9.
28. Rentsch-Granges V, Assal F, Pereira VM, Alimenti A, Mosimann P, de Ribaupierre A, et al. ADC mapping of chronic cerebral hypoperfusion induced by carotid artery stenosis. J Neuroradiol. 2011;38:232-7.
29. L övblad KO, Delavelle J, Wetzel S, Kelekis AD, Assal F, Pamesino M, et al. ADC mapping of the aging frontal lobes in mild cognitive impairment. Neuroradiology. 2004;46:282-6.
30. Geurts JJG, Stys PK, Minagar A, Amor S, Zivanidov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci. 2009;282:12-20.
31. Song CJ, Kim JH, Kier EL, Bronen RA. MR imaging and histologic features of subinsular bright spots on T2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology. 2000;214:671-7.
32. V alk J, Barkhof F, Scheltens P. Magnetic resonance in dementia. Berlin: Springer; 2003 (chapter 6.3.2).
33. Gess B, Niederstadt TU, Ringelstein EB, Schäbitz WR. Clinical relevance of normal and enlarged Virchow-Robin spaces. Nervenarzt. 2010;81:727-33.
34. Doubal FN, MacLullich AMJ, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41:450-4.
35. Rouhl RPW, van Oostenbrugge RJ, Knottnerus ILH, Staals JEA, Lodder J. Virchow-Robin spaces relate to cerebral small vessel disease severity. J Neurol. 2008;255:692-6.
36. L ake, B. Lysosomal and peroxisomal disorders. In: Graham DI, Lantos PL, Editors. Greenfield's neuropathology Vol 1. London: Arnold. 1997; pp. 657-753.
37. Grodd, W. Stoffwechselerkrankungen. In: Forsting M, Jansen O. MRT des Zentralnervensystems. Stuttgart: Thieme; 2005. pp. 248-293.
38. Murata R, Nakajima S, Tanaka A, Miyagi N, Matsuoka O, Kogame S, et al. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol. 1989;10:1165-70.
39. Rasalkar DD, Chu WC, Hui J, Chu CM, Paunipagar BK, Li CK. Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine. Br J Radiol. 2011;84:469-77.
40. Ringelstein EB, Kleffner I, Dittrich R, Kuhlenbäumer G, Ritter MA. Hereditary and non-hereditary microangiopathies in the young. An up-date. J Neurol Sci. 2010;299:81-5.
41. Kruit MC, van Buchem MA, Hofman PA, Bakkers JTN, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427-34.
42. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol. 1998;245:116-22.
43. Grinberg LT , Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol. 2010;119:277-90.
44. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701.
45. Bateman GA. Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus. Med Hypotheses. 2004;62:182-187.
46. W ardlaw JM, Farrall A, Armitage PA, Carpenter T, Chappell F, Doubal F, et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke. 2008;39:1327-32.
47. Henry Feugeas MC, De Marco G, Peretti II, Godon-Hardy S, Fredy D, Claeys ES. Age-related cerebral white matter changes and pulse-wave encephalopathy: observations with three-dimensional MRI. J Magn Reson Imaging. 2005;23:929-37.
48. Schmidt R, Grazer A, Enzinger C, Ropele S, Homayoon N, Pluta- Fuerst A, et al. MRI-detected white matter lesions: do they really matter? J Neural Transm. 2011;118:673-81.
49. Black S, Gao F, Bilbao J. Understanding white matter disease imaging-pathological correlations in vascular cognitive impairment. Stroke. 2009;40(Suppl 1):48-52.
50. Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, et al. Impact of age-related cerebral white matter changes on the transition to disability-the LADIS study: rationale, design and methodology. Neuroepidemiology. 2005;24:51-62.
51. Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, Kleinert G, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-9.
52. Simpson JE, Ince PG, Higham CE, Gelsthorpe CH, Fernando MS, Matthews F, et al. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol. 2007;33:670-83.
53. Fernando MS, Simpson JE, Matthews FE, Brayne C, Lewis CE, Barber R, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391-8.
54. Barkhof F, Scheltens P. Is the whole brain periventricular? J Neurol Neurosurg Psychiatry. 2006;77:143-4.
55. Pekkala JS, Mamourian AC, Wishart HA, Hickey WF, Raque JD. Focal lesion in the splenium of corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy. AJNR Am J Neuroradiol. 2003;24:855-61.
56. E nzinger C, Smith S, Fazekas F, Drevin G, Ropele S, Nichols T, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol. 2006;253:1064-70.
57. W en W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60 to 64-year-old individuals. NeuroImage. 2004;22:144-51.
58. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122:17-26.
59. Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP, et al. Acute disseminated encephalomyelitis. An update. Arch Neurol. 2005;62:1673-80.
60. I nzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.
61. Oksala NKL, Oksala A, Pohjasvaara T, Vataja R, Kaste M, Karhunen PJ, et al. Age related white matter changes predict stroke death in long term follow-up. J Neurol Neurosurg Psychiatry. 2009;80:762-6.
62. C hen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology. 2006;67:83-7.
63. Roher AE, Kuo Y-M, Esh C, Knebel C, Weiss N, Kalback W, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med. 2003;9:112-22.
64. W eller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009;117:1-14.
65. Gouw AA, Van Der Flier WM, van Straaten EC, Barkhof F, Ferro JM, Baezner H, et al. LADIS study group. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol. 2006;253:1189-96.
66. V an Der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36:2116-20.
67. Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical infarcts, Alzheimer's disease pathology and memory function in older persons. Ann Neurol. 2007;62:59-66.
68. Fernando MS, Ince PG. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci. 2004;226:13-7.
69. V ernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MMB, Van Der Lugt A. Cerebral microbleeds: accelerated 3DT2*-weighted GRE MR imaging versus conventional 2DT2*- weighted GRE MR imaging for detection. Radiology. 2008;248: 272-7.
70. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradientecho T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20:637-42.
71. C halla VR, Moody DM, Bell MA. The Charcot-Bouchard aneurysm controversy: impact of a new histologic technique. J Neuropathol Exp Neurol. 1992;51:264-71.
72. Pettersen JA, Sathiyamoorthy G, Gao FQ, Szilagyi G, Nadkarni NK, George-Hyslop PS, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol. 2008;65:790-7.
73. Goos JDC, Kester MI, Barkhof F, Klein M, Blankenstein MA, Scheltens P, et al. Patients with Alzheimer disease with multiple microbleeds. Relation with cerebrospinal fluid biomarkers and cognition. Stroke. 2009;40:3455-60.
74. L inn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74:1346-50.
75. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol. 2011;37:94-113.
76. de Lau LM, Leebeek FW, de Maat MP, Koudstaal PJ, Dippel DW. Screening for coagulation disorders in patients with ischemic stroke. Expert Rev Neurother. 2010;10:1321-9.
77. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2004;127:212-9.
78. Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162:2078-85.
79. A uer DP, Pütz B, Gössl C, Elbel GK, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443-51.
80. Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol. 2005;26:2481-7.
81. Hervé D, Mangin J-F, Molko N, Bousser M-G, Chabriat H. Shape and volume of lacunar infarcts: a 3D MRI study in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy. Stroke. 2005;36:2384-88.
82. Moore DF, Kaneski CR, Askari H, Schiffmann R. The cerebral vasculopathy of Fabry disease. J Neurol Sci. 2007;257:258-63.
83. Moore DF, Ye F, Schiffmann R, Butman JA. Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol. 2003;24:1096-101.
84. L erman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab. 2005;84:127-36.
85. Burlina AP, Manara R, Caillaud C, Laissy JP, Severino M, Klein I, et al. The pulvinar sign: frequency and clinical correlations in Fabry disease. J Neurol. 2008;255:738-44.
86. L evine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752-63.
87. Mayer M, Cerovec M, Rados M, Cikes N. Antiphospholipid syndrome and central nervous system. Clin Neurol Neurosurg. 2010;112:602-8.
88. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol. 1996;167:1573-8.
89. Ferreira S, D'Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology. 2005;44:434-42.
90. Rovaris M, Viti B, Ciboddo G, Gerevini S, Capra R, Iannucci G, et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study. J Neurol Neurosurg Psychiatry. 2000;68:170-7.
91. Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, et al. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol. 2010;257:63-71.
92. Geissler A, Andus T, Roth M, Kullmann F, Caesar I, Held P, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet. 1995;345:897-8.
93. T heodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry. 2006;77:290-5.
94. Do TH, Fisch C, Evoy F. Susac syndrome: report of four cases and review of the literature. AJNR Am J Neuroradiol. 2004;25:382-8.
95. Susac JO. Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology. 1994;44:591-3.
96. Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, et al. MRI findings in Susac's syndrome. Neurology. 2003;61:1783-7.
97. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5:501-12.
98. Steen GR, Xiong X, Langston JW, Helton KJ. Brain injury in children with sickle cell disease: prevalence and etiology. Ann Neurol. 2003;54:564-72.
99. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities. Arch Neurol. 2004;61:1366-8.
100. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population based MRI CAMERA study. Brain. 2005;125:2068-77.
101. Scolding NJ. Central nervous system vasculitis. Semin Immunpathol. 2009;31:527-36.
102. Berlit P. Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. 2010;3:29-42.
103. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 2007;62:442-51.
104. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68:1411-16.
105. Kloppenborg RP, Richard E, Sprengers MES, Troost D, Eikelenboom P, Nederkoorn PJ. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment. J Neuroinflammation. 2010;7:7-18.
106. Urban PP, Müller-Forell W. Clinical and neuroradiological spectrum of isolated cerebral vein thrombosis. J Neurol. 2005;252:1476-81.
107. A kman-Demir G, Serdaroglu P, Tasci B. The Neuro-Behcet Study Group. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. Brain. 1999;122:2171-81.
108. Siva A. Vasculitis of the nervous system. J Neurol. 2001;248:451-68.
109. Haghighi AB, Sharifzad HR, Matin S, Rezaee S. The pathological presentations of neuro-Behçet disease: a case report and review of the literature. Neurologist. 2007;13:209-14.
110. Ku BD, Shin HY. Multiple bilateral non-hemorragic cerebral infarctions associated with microscopic polyangiitis. Clin Neurol Neurosurg. 2009;111:904-6.
111. Hilton-Jones D, Ironside JW, Simpson DJ. A young man with rapidly progressive multifocal disease affecting the white matter. Pract Neurol. 2007;7:172-81.
112. Jenette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512-23.
113. Molloy ES, Singhal AB, Calabrese LH. Tumor-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis. 2008;67:1567-9.
114. Myung J, Kim B, Yoon BW, Lee SK, Sung JJ, Chung CK, et al. B-cell dominant lymphocytic primary angiitis of the central nervous system: four biopsy-proven cases. Neuropathology. 2010;30:123-30.
115. L ie JT. Primary granulomatous angiitis of central nervous system: a clinico-pathologic analysis of 15 new cases and a review of the literature. Hum Pathol. 1992;23:164-71.
116. T erushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16:2-15.
117. Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Arch Neurol. 2009;66:704-9.
118. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397-407.
119. Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg. 2010;112:625-8.
120. T opakian R, Stieglbauer K, Nussbaumer K, Aichner FT. Cerebral vasculitis and stroke in lyme neuroborreliosis. Cerebrovasc Dis. 2008;26:455-61.
121. Panegyres PK. Diagnosis and management of Whipple's disease of the brain. Pract Neurol. 2008;8:311-7.
122. C hristoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol. 1999;20:655-9.
123. Bartynsky WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036-42.
124. Bartynsky WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-9.
125. Kang S-Y, Kang JH, Choi JC, Lee JS. Posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria. J Neurol. 2010;257:663-4.
126. W eidauer S, Gaa J, Sitzer M, Hefner R, Lanfermann H, Zanella FE. Posterior encephalopathy with vasospasm: MRI and angiography. Neuroradiology. 2003;45:869-76.
127. Bas DF, Oguz KK, Topcuoglu MA. Atypical reversible posterior leucencephalopathy syndrome in thrombotic thrombocytopenic purpura. Inter Med. 2008;47:1931-4.
128. Burrus TM, Wijdicks EF, Rabinstein AA. Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology. 2009;73:66-70.
129. L ee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of revesible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205-10.
130. T homas MP, Wang A. Clinical problem-solving. Taken out of context. N Engl J Med. 2008;359:2478-82.
131. Renard D, Dutray A, Le Quellec A, Milhaud D. Reversible posterior leukoencephalopathy syndrome in catastrophic antiphospholipid syndrome. Cerebrovasc Dis. 2007;24:141-3.
132. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091-101.
133. Kugler Y, Wiest R, Sturzenegger M. Migräne, Insult, Epilepsie oder alle drei?-Die vielen Gesichter des MELAS-Syndroms. Schweiz Med Forum. 2007;7:123-9.
134. I to H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like in MELAS. Brain Dev. 2008;30:483-8.
135. T estai FD, Gorelick PB. Inherited metabolic disorders and stroke. Part I. Arch Neurol. 2010;67:9-24.
136. Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter neuroanatomy, clinical neurology and neurobehavioral correlates. Ann NY Acad Sci. 2008;1142:266-309.
137. Schiffmann R, Van Der Knaap MS. An MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72:750-9.